Laboratory Corporation of America Holdings (LH)

Debt-to-capital ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands 5,331,200 4,054,700 5,038,800 5,416,500 5,419,000
Total stockholders’ equity US$ in thousands 8,052,200 7,875,000 10,096,600 10,273,400 9,436,600
Debt-to-capital ratio 0.40 0.34 0.33 0.35 0.36

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $5,331,200K ÷ ($5,331,200K + $8,052,200K)
= 0.40

The debt-to-capital ratio of Laboratory Corporation of America Holdings has shown a slight fluctuation over the past five years. Starting at 0.36 in December 31, 2020, it decreased to 0.35 by December 31, 2021, further declining to 0.33 by December 31, 2022. However, there was a slight increase to 0.34 by December 31, 2023, followed by a notable rise to 0.40 by December 31, 2024.

Despite the fluctuations, the general trend indicates that the company's reliance on debt as a source of capital has varied over the years. A decreasing debt-to-capital ratio may suggest a more conservative capital structure, indicating lower financial risk. Conversely, an increasing ratio may imply higher leverage, potentially leading to increased financial risk. It would be important for stakeholders to further examine the reasons behind these changes and consider the potential impact on the company's financial health and strategic decisions.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-capital ratio
Laboratory Corporation of America Holdings
LH
0.40
Fortrea Holdings Inc.
FTRE
0.44
Fulgent Genetics Inc
FLGT
0.00
Quest Diagnostics Incorporated
DGX
0.41
RadNet Inc
RDNT
0.52